Adipokines have long been the province of metabolic research rather than emergency medicine. These molecules, secreted by white adipose tissue, act as chemical messengers that influence appetite, insulin sensitivity, and immune activity throughout the body. Among the most studied are adiponectin, which generally exerts anti-inflammatory and protective effects on blood vessels and kidneys, and resistin, which in humans is produced largely by immune cells and is strongly associated with inflammatory activation. Leptin and retinol-binding protein 4 round out the panel, each carrying its own metabolic and immunological signatures. What has remained unclear is how this hormonal ensemble behaves in the acute chaos of major trauma, and whether its behavior carries any clinical meaning for patients fighting for their lives in intensive care.

To find out, the Ulm team, led by Lena Schütte and Rebecca Halbgebauer, conducted a secondary retrospective analysis of a longitudinal observational cohort, drawing on prospectively collected plasma samples and clinical data from 67 patients with an Injury Severity Score of at least 16, a threshold defining severe polytrauma. They compared these patients with 31 healthy volunteers. Blood was drawn at four time points: on admission to hospital, and then on days one, five, and ten. At each point, the researchers measured circulating levels of resistin, adiponectin, leptin, and retinol-binding protein 4, alongside a battery of inflammatory markers and clinical indicators of organ function.

The statistical approach was deliberately rigorous. Because adipokine levels are known to vary with body composition, age, and sex, the team used linear mixed-effects models adjusted for age, sex, body mass index, and waist-to-hip ratio, the latter derived from computed tomography scans as a measure of body-fat distribution. Associations with inflammatory markers and organ dysfunction were assessed using partial Spearman correlations, and the researchers applied false discovery rate correction to guard against spurious findings that arise when many comparisons are made simultaneously. Exploratory receiver-operating characteristic analyses were then used to ask whether adipokine measurements could classify clinically meaningful outcomes, including length of hospital stay, length of intensive care stay, shock severity, and 30-day mortality.

The results were striking from the very first blood draw. Compared with healthy volunteers, trauma patients arrived at the hospital with a fundamentally altered adipokine profile: resistin was significantly elevated, while adiponectin was significantly reduced. This reciprocal shift, an increase in a pro-inflammatory signal paired with a decrease in a protective one, suggests that severe injury rapidly reprograms the endocrine output of fat tissue and the immune cells that produce these hormones. The changes were not subtle statistical whispers but robust differences detectable at admission, before most clinical interventions had time to exert their own effects on the circulating hormone landscape.

Perhaps the most compelling finding was the strength of the relationship between resistin and interleukin-6, one of the central cytokines driving the post-traumatic inflammatory response. At admission, resistin levels correlated with IL-6 at approximately 0.75, a correlation strong enough to survive false discovery rate correction. In biological terms, this means that patients whose blood carried the highest resistin concentrations were also mounting the most intense inflammatory responses. Resistin, in this context, appears less as a bystander and more as a potential readout of the immune system’s overall state of activation in the hours following injury.

When the researchers combined the two opposing signals into a single metric, the resistin-to-adiponectin ratio, they found the most consistent pattern of associations across the entire study. This ratio tracked with both inflammatory parameters and markers of renal dysfunction, including measures of kidney function such as estimated glomerular filtration. The kidney connection is particularly intriguing, because adiponectin has well-documented protective effects on renal tissue, and acute kidney injury is one of the most common and dangerous complications of severe trauma. A falling adiponectin level paired with rising resistin may therefore reflect, or even contribute to, the vulnerability of the kidneys during the critical early days after injury.

The exploratory outcome analyses offered cautious grounds for optimism, tempered by important limitations. Several adipokine measures showed moderate ability to classify selected clinical outcomes, such as length of hospital or intensive care stay and shock severity, in receiver-operating characteristic analyses. However, the mortality analyses were hampered by the small number of death events available at the later time points, making any conclusion about predicting survival statistically fragile. The authors are explicit that these outcome associations are exploratory and require prospective, multicenter validation before any claim of added clinical value beyond conventional parameters, such as the Sequential Organ Failure Assessment score, can be made.

One of the study’s secondary questions concerned whether body-fat distribution shapes the adipokine response to trauma. Using CT-derived waist-to-hip ratios, the researchers stratified patients and looked for differences in hormone profiles. For the most part, the stratified comparisons showed no clear separation across groups, suggesting that the dramatic adipokine shifts triggered by severe injury may override the more gradual influence of body composition, at least within the first ten days. This is a useful negative finding, because it implies that the trauma-induced adipokine signature could potentially serve as a standardized marker across patients of varying body types, though the authors note that most WHR-stratified differences were limited.

The broader significance of this work lies in its reframing of fat tissue as an active participant in the response to injury rather than a passive energy depot. The concept of immunometabolism, the interplay between immune signaling and metabolic regulation, has gained momentum across critical care research, and this study provides some of the most detailed longitudinal human data on adipokines in polytrauma to date. If future multicenter studies confirm that the resistin-to-adiponectin ratio adds predictive power for organ dysfunction beyond existing clinical scores, it could eventually help clinicians identify, within hours of admission, which patients are most likely to develop kidney injury or multi-organ dysfunction, opening a window for earlier and more targeted interventions. For now, the message is one of careful promise: the body’s fat-derived hormones respond to trauma with remarkable speed and specificity, and their story is only beginning to be told.

Subject of Research: Adipokine dynamics and their association with inflammation and acute organ dysfunction after severe polytrauma

Article Title: Inflammation-linked adipokine profiles associate with acute organ dysfunction after severe trauma

Article References: Schütte, L., Oßwald, K., Mannes, M., Wohlgemuth, L., Kumral, E., Mayer, B., Bülow, J. M., Bergmann, C. B., Relja, B., Gebhard, F., Huber-Lang, M., Fischer-Posovszky, P., Rayatdoost, F., & Halbgebauer, R. (2026). Inflammation-linked adipokine profiles associate with acute organ dysfunction after severe trauma. Journal of Translational Medicine, 24(1), Article 1176. https://doi.org/10.1186/s12967-026-08968-4

Image Credits: AI Generated

DOI: 10.1186/s12967-026-08968-4

Keywords: adipokines, polytrauma, resistin, adiponectin, inflammation, organ dysfunction, acute kidney injury, interleukin-6, biomarkers, immunometabolism, intensive care, trauma surgery